Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength?
Crinetics Pharmaceuticals, Inc. CRNX shares rallied 98.7% in the last trading session to close at $83.53. This move can be…
The Archive
Every market briefing, in one place.
In-depth analysis on the Fed, earnings, labor, commodities, and the news that moves markets. Filter by topic to find what you’re looking for.
The Economy Is Slowing: 2 TSX Stocks I’d Still Buy Today
There are growing signs in the economy that things are slowing down. GDP growth has remained roughly flat for much…
XRP Eyes a Top 5 Comeback—Can the Price Break Above $1.20?
The XRP price has come under renewed selling pressure, plunging nearly 3% over the past 24 hours as it continues…
MediaFuse launches TechnologyWire for tech-focused press release distribution
MediaFuse, the company behind PR distribution platforms including Chainwire, CyberNewsWire, GamingWire, and FinanceWire, has announced the launch of TechnologyWire, a…
Target's latest move could win over back-to-school shoppers
Back-to-school shopping isn’t just about filling a backpack anymore. Parents want affordable basics. But they also want clothes and accessories…
RBI Reiterates Crypto Ban Call, but No Policy Change Announced
Trust with CoinPedia: CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created…
A New CRISPR “DNA Shredder” Could Change Gene-Editing — What It Means for CRISPR Therapeutics
Key Points Gene-editing is a handy tool for developing sophisticated medicines. A new CRISPR molecule can destroy cells that express…
The TSX Is Facing a New Reality: 2 Stocks to Watch Now
With the TSX Index continuing its impressive rally into the hottest parts of summer, investors might be wondering if it’s…
BTC, ETH Tumble After Trump Says Iran Ceasefire Is Over
Crypto market today turned sharply lower within minutes as panic selling swept through digital assets following a major geopolitical escalation.…